Aiming for the Best Control of Glycemia in Patients With Heart Failure and Type 2 Diabetes. The "Sweet Spot"

Journal of the American College of Cardiology

Volumn 54, Issue 5, 2009, Pages 429-431

  Weinrauch, Larry A ^a   Lewis, Eldrin F ^a  

^a MOUNT AUBURN HOSPITAL   (United States)

Author keywords

diabetes; glycosylated hemoglobin; HbA1c; heart failure; prognosis

Indexed keywords

HEMOGLOBIN A1C;

DIABETIC PATIENT; EDITORIAL; GLYCEMIC CONTROL; HEART FAILURE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; TREATMENT PLANNING;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HEART FAILURE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS;

EID: 67650668235     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.05.014     Document Type: Editorial

References (14)

1. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. (erratum N Engl J Med 2000;342:1376). N Engl J Med 342 (2000) 381-389
2. Nathan D.M., Cleary P.A., Backlund J.Y., et al., Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 353 (2005) 2643-2653
3. Kosiborod M., Inzucchi S.E., Krumholz H.M., et al. Glucose normalization and outcomes in patients with acute myocardial infarction. Arch Intern Med 169 (2009) 438-446
4. Van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in critically ill patients. N Engl J Med 345 (2001) 1359-1367
5. Finfer S., Chittock D.R., Su S.Y., et al., NICE-SUGAR Study Investigators. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 360 (2009) 1283-1297
6. Patel A., MacMahon S., Chalmers J., et al., ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 358 (2008) 2560-2572
7. Duckworth W., Abraira C., Moritz T., et al., VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360 (2009) 129-139
8. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., and Neil H.A. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 359 (2008) 1577-1589
9. U.K. Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). (erratum Lancet 1998;352:1558). Lancet 352 (1998) 854-865
10. U.K. Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). (erratum Lancet 1999;354:602). Lancet 352 (1998) 837-853
11. Aguilar D., Bozkurt B., Ramasubbu K., and Deswal A. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes. J Am Coll Cardiol 54 (2009) 422-428
12. Kosiborod M., Inzucchi S.E., Goyal A., et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 301 (2009) 1556-1564
13. Gerstein H.C., Miller M.E., Byington R.P., and Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 358 (2008) 2545-2559
14. Geltman J., Sun J., Keenan H., et al. Unexpected high prevalence of cardiovascular complications in type 1 diabetes of extreme duration. (abstr). Diabetes 58 Suppl 1 (2009) A199